Magnus Janzon Selected Research

Hemorrhage

1/2021	Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy-An observational study.
4/2020	Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategies.
1/2020	Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
4/2019	Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
1/2019	Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
9/2017	Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
4/2016	Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
2/2013	Cost-effectiveness of ticagrelor in acute coronary syndromes.
1/2013	Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
1/2010	Costs of bleeds relating to acute coronary syndrome therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Janzon Research Topics

Disease

23	ST Elevation Myocardial Infarction 04/2020 - 12/2008
18	Myocardial Infarction 01/2023 - 10/2009
10	Hemorrhage 01/2021 - 01/2010
10	Stroke (Strokes) 04/2020 - 02/2011
10	Thrombosis (Thrombus) 01/2020 - 08/2013
8	Acute Coronary Syndrome 01/2023 - 01/2010
5	Infarction (Infarctions) 09/2014 - 03/2010
4	Atrial Fibrillation 01/2023 - 01/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2009
3	Diabetes Mellitus 04/2019 - 07/2012
3	Chest Pain (Chest Pains) 04/2019 - 01/2013
3	Heart Diseases (Heart Disease) 01/2019 - 01/2018
2	Coronary Disease (Coronary Heart Disease) 05/2021 - 08/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2010
1	Emphysema 01/2024
1	Hypercholesterolemia 01/2022
1	Acute Pain 04/2019
1	Unstable Angina 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Death (Near-Death Experience) 01/2019
1	Thromboembolism 01/2018
1	Ischemia 01/2018
1	Reperfusion Injury 02/2012
1	Cicatrix (Scar) 02/2012
1	Renal Insufficiency (Renal Failure) 02/2011
1	Stable Angina 01/2010
1	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 10/2009
1	Tachycardia (Tachyarrhythmias) 10/2009

Drug/Important Bio-Agent (IBA)

15	TicagrelorIBA 01/2023 - 01/2013
11	Abciximab (ReoPro)FDA Link 08/2015 - 12/2008
10	Clopidogrel (Plavix)FDA Link 04/2020 - 01/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019 - 02/2011
2	Purinergic P2Y Receptor AntagonistsIBA 04/2019 - 09/2014
2	omega-Chloroacetophenone (Mace)IBA 01/2019 - 03/2010
2	AnticoagulantsIBA 01/2018 - 05/2017
2	Troponin T (Troponin T1)IBA 12/2014 - 01/2013
2	Trinitrotoluene (TNT)IBA 12/2014 - 01/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 02/2011
1	CalciumIBA 01/2024
1	LDL CholesterolIBA 01/2022
1	CholesterolIBA 01/2022
1	LipidsIBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Platelet Membrane Glycoprotein IIbIBA 04/2019
1	Adenosine Diphosphate (ADP)IBA 04/2019
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 04/2019
1	Morphine (MS Contin)FDA LinkGeneric 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Anti-Arrhythmia AgentsIBA 01/2015
1	Dabigatran FDA Link 01/2013
1	reteplase FDA Link 08/2010
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2010
1	Biomarkers (Surrogate Marker)IBA 01/2010

Therapy/Procedure

20	Percutaneous Coronary Intervention 01/2020 - 08/2009
14	Therapeutics 01/2023 - 01/2010
10	Stents 01/2020 - 08/2013
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 01/2010
2	Radiofrequency Ablation 01/2015 - 10/2009
1	Secondary Prevention 01/2020
1	Catheter Ablation 01/2015
1	Time-to-Treatment 02/2012
1	Treatment Delay 02/2012
1	Thrombolytic Therapy 01/2010
1	Punctures 01/2010
1	Length of Stay 01/2010